Cited by 197Peroxisome Proliferator-Activated ReceptorsLiver physiology and pathologyLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells

Open access

Galli, Andrea, Crabb, David, Price, Donna, Ceni, Elisabetta, Salzano, Renata, Surrenti, Calogero, Casini, Alessandro·2000·Hepatology

DOI 10.1002/hep.510310117

Open this paper in CoChat — free account Open PDF

Abstract

During liver injury, hepatic stellate cells (HSC) acquire a myofibroblast-like phenotype associated with reduction of lipid droplets, increased collagen synthesis, and proliferation. Peroxisome proliferator-activated receptor γ (PPARγ) regulates adipocyte differentiation and controls gene transcription in response to various activators including prostanoids and antidiabetic thiazolidinediones. We explored whether the presence of PPARγ and its transcriptional activity were involved in control of HSC proliferation in vitro. PPARγ ligands, 15-deoxy-△12 14 prostaglandin J 2 (15d-PGJ 2) and ciglitizone, significantly decrease platelet-derived growth factor (PDGF)-induced proliferation in activated human HSC and inhibit α smooth muscle actin (α-SMA) expression during HSC transdifferentiation. Treatment with 9-cis retinoic acid (9-cisRA) and LG268, ligands of the heterodimerization partner retinoic X receptor (RXR), had a negligible effect in PDGF-treated cells but caused a further reduction of proliferation when used in combination with ciglitizone. Transfection experiments with a reporter gene consisting of 3 copies of a PPAR response element (peroxisome proliferator response element [PPRE]3-tk-luciferase) showed a progressive reduction of PPAR transcriptional activity during plastic-induced HSC transdifferentiation. Cotransfection with human PPARγ expression vector restored the PPRE 3-tk-luciferase reporter expression and the increased level of the receptor in activated HSC-inhibited cell proliferation in a dose-dependent manner. Incubation of human PPARγ-cotransfected HSC with PDGF strongly inhibited luciferase activity and this effect was blocked by the inhibition of the mitogen-activated protein (MAP) kinase signal cascade. Our results indicate that depression of PPARγ expression and activity is involved in HSC proliferation and that the PPARγ ligand-mediated activation exerts a previously unrecognized inhibition of PDGF-induced mitogenesis in activated human HSC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.510310117

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Firefly Luciferase Gene: Structure and Expression in Mammalian Cells
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. E. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,088
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
FORMAN, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,857
A rapid micrqpreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,337
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Preprint
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164

Show all 52 references

Research works printed but not linked: 4

Pinzani, 1996, Am J Pathol, 148, 785
Andrews, Nucl Acids Res, 19, 680
Guan, 1997, Am J Physiol, 273, f1013
Sakai, 1995, Cancer Res, 55, 5370

Sorted by citations

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
The Myofibroblast
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Self-citation
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440
Self-citation
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1055-4 · Cited by 421
Curcumin Protects the Rat Liver from CCl4-Caused Injury and Fibrogenesis by Attenuating Oxidative Stress and Suppressing Inflammation
Fu, Y., Zheng, S., Lin, J., Ryerse, J. S., & Chen, A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039818 · Cited by 396
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial
Ratziu, V., Charlotte, F., Bernhardt, C., Giral, P., Halbron, M., Naour, G. L., Hartemann–Heurtier, A., Bruckert, É., & Poynard, T. (2009) · Hepatology · doi:10.1002/hep.23270 · Cited by 366
Mechanisms of liver fibrosis
Tsukada, S., Parsons, C. J., & Rippe, R. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 355
Liver fibrosis: from the bench to clinical targets
Pinzani, M., & Rombouts, K. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.01.003 · Cited by 337
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
Guan, Y., & Breyer, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00766.x · Cited by 292
Hepatic Stellate Cells: Unique Characteristics in Cell Biology and Phenotype
Sato, M., Suzuki, S., & Senoo, H. (2003) · Cell Structure and Function · doi:10.1247/csf.28.105 · Cited by 292
Roles of PPARs in NAFLD: Potential therapeutic targets
Tailleux, A., Wouters, K., & Staels, B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.016 · Cited by 289
Regulation of Bile Acid and Cholesterol Metabolism by PPARs
Li, T., & Chiang, J. Y. L. (2009) · PPAR Research · doi:10.1155/2009/501739 · Cited by 260
Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2‐mediated mechanism†
Galli, A., Svegliati‐Baroni, G., Ceni, E., Milani, S., Ridolfi, F., Salzano, R., Tarocchi, M., Grappone, C., Pellegrini, G., Benedetti, A., et al. (2005) · Hepatology · doi:10.1002/hep.20683 · Cited by 235
Self-citation
The Transcriptional and DNA Binding Activity of Peroxisome Proliferator-activated Receptor α Is Inhibited by Ethanol Metabolism
Galli, A., Pinaire, J. A., Fischer, M., Dorris, R., & Crabb, D. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008791200 · Cited by 226
Self-citation
Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex
Eng, F. J., & Friedman, S. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.1.g7 · Cited by 222
Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth
Xu, J., Fu, Y., & Chen, A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00474.2002 · Cited by 217
Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases
Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J. H., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 201
Hepatic stellate cell (vitamin A‐storing cell) and its relative – past, present and future
Senoo, H., Yoshikawa, K., Morii, M., Miura, M., Imai, K., & Mezaki, Y. (2010) · Cell Biology International · doi:10.1042/cbi20100321 · Cited by 198
Transcriptional regulation of hepatic stellate cell activation: Figure 1
Mann, D. A., & Smart, D. E. (2002) · Gut · doi:10.1136/gut.50.6.891 · Cited by 191
Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Morelli, A., Pruzanski, M., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085597 · Cited by 177
Involvement of P21Waf1/Cip1, P27Kip1, and P18Ink4c in Troglitazone–Induced Cell–Cycle Arrest in Human Hepatoma Cell Lines
Koga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24024 · Cited by 175
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet
Kawaguchi, K., Sakaida, I., Tsuchiya, M., Omori, K., Takami, T., & Okita, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.038 · Cited by 160
Alcohol induced hepatic fibrosis: Role of acetaldehyde
Mello, T., Ceni, E., Surrenti, C., & Galli, A. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.10.001 · Cited by 160
Self-citation
15-Deoxy-Δ12,14-prostaglandin J2 Induces Apoptosis of Human Hepatic Myofibroblasts
Li, L., Tao, J., Davaille, J., Féral, C. C., Mallat, A., Lotersztajn, S., Rieusset, J., & Vidal, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101980200 · Cited by 153
A PPARγ, NF-κB and AMPK-Dependent Mechanism May Be Involved in the Beneficial Effects of Curcumin in the Diabetic db/db Mice Liver
Jiménez-Flores, L. M., López-Briones, S., Macías-Cervantes, M. H., Ramı́rez-Emiliano, J., & Pérez‐Vázquez, V. (2014) · Molecules · doi:10.3390/molecules19068289 · Cited by 157
Molecular regulation of pancreatic stellate cell function.
Jaster, R. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-26 · Cited by 156
Aldehyde Dehydrogenase, Liver Disease and Cancer
Wang, W., Wang, C., Xu, H., & Gao, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42300 · Cited by 150
Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage
Wang, C., Ciliberti, N., Li, S., Szmitko, P. E., Weisel, R. D., Fedak, P. W. M., Al-Omran, M. A., Cherng, W., Li, R., Stanford, W. L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000123231.49594.21 · Cited by 144
PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progression
Fischer, A. N. M., Fuchs, E., Mikula, M., Huber, H., Beug, H., & Mikulits, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210121 · Cited by 146
Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S -Transferase Gene by the Peroxisome Proliferator-Activated Receptor-γ and Retinoid X Receptor Heterodimer
Park, E. Y., Cho, I. J., & Kim, S. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3924 · Cited by 135
Ligands of Peroxisome Proliferator-activated Receptor-γ Block Activation of Pancreatic Stellate Cells
Masamune, A., Kikuta, K., Satoh, M., Sakai, Y., Satoh, A., & Shimosegawa, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107582200 · Cited by 142
Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells
Hellemans, K., Michalik, L., Dittie, A., Knorr, A., Rombouts, K., de Jong, J., Heirman, C., Quartier, E., Schuit, F., Wahli, W., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50015 · Cited by 137
Mechanisms and Therapy of Hepatic Fibrosis: Report of the Aasld Single Topic Basic Research Conference
Friedman, S. L., Maher, J. J., & Bissell, M. D. (2000) · Hepatology · doi:10.1053/jhep.2000.20243 · Cited by 135
Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation
Luk, J. M., Wang, X., Liu, P., Wong, K., Chan, K., Tong, Y., Hui, C. K., Lau, G. K. K., & Fan, S. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01527.x · Cited by 136
THE ROLE OF FIBROBLAST TRANSDIFFERENTIATION IN LUNG EPITHELIAL CELL PROLIFERATION, DIFFERENTIATION, AND REPAIR IN VITRO
Torday, J. S., Torres, E., & Rehan, V. K. (2003) · Fetal and Pediatric Pathology · doi:10.1080/pdp.22.3.189.207 · Cited by 135
The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)
Nati, M., Haddad, D., Birkenfeld, A. L., Koch, C. A., Chavakis, T., & Chatzigeorgiou, A. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9339-2 · Cited by 138
Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity
Giannini, S., Serio, M., & Galli, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347546 · Cited by 133
Self-citation
Troglitazone and liver injury
Chojkier, M. (2005) · Hepatology · doi:10.1002/hep.20567 · Cited by 129
A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation
Bisht, S., Khan, M. A., Bekhit, M., Bai, H., Cornish, T. C., Mizuma, M., Rudek, M. A., Zhao, M., Maitra, A., Ray, B., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.86 · Cited by 118
Alcohol Abuse: Critical Pathophysiological Processes and Contribution to Disease Burden
Molina, P. E., Gardner, J. D., Souza‐Smith, F. M., & Whitaker, A. M. (2014) · Physiology · doi:10.1152/physiol.00055.2013 · Cited by 120
Activation of PPARγ is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro
Zheng, S., & Chen, A. (2004) · Biochemical Journal · doi:10.1042/bj20040928 · Cited by 115
Molecular basis of hepatic fibrosis
Hui, A., & Friedman, S. L. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005684 · Cited by 116
Curcumin inhibits gene expression of receptor for advanced glycation end‐products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress
Lin, J., Tang, Y., Kang, Q., Feng, Y., & Chen, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01910.x · Cited by 111
Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cellsin vitroby blocking NF‐κB and ERK signalling
Chen, A., & Zheng, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707542 · Cited by 110
The stellate cell system (vitamin A-storing cell system)
Senoo, H., Mezaki, Y., & Fujiwara, M. (2017) · Anatomical Science International · doi:10.1007/s12565-017-0395-9 · Cited by 112
Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats
Hayashizaki, Y., Kurosaki, E., Takasu, T., Mitori, H., Yamazaki, S., Koide, K., & Takakura, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.009 · Cited by 107
Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes11Abbreviations: PPAR, peroxisome proliferator-activated receptor; 15d-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2; NEFA, non-esterified fatty acid; T2DM, type 2 (non-insulin-dependent) diabetes mellitus; LPS, lipopolysaccharide; NSAIDs, nonsteroidal anti-inflammatory drugs; IL, interleukin; TNF α, tumor necrosis factor-α; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; and TZD, thiazolidinedione.
Boelsterli, U. A., & Bedoucha, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00817-6 · Cited by 103
Curcumin suppresses expression of low‐density lipoprotein (LDL) receptor, leading to the inhibition of LDL‐induced activation of hepatic stellate cells
Kang, Q., & Chen, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00261.x · Cited by 106
Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches
Ahmad, R., & Ahmad, A. (2012) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.96445 · Cited by 105
Pioglitazone Prevents Early-Phase Hepatic Fibrogenesis Caused by Carbon Tetrachloride
Kon, K., Ikejima, K., Hirose, M., Yoshikawa, M., Enomoto, N., Kitamura, T., Takei, Y., & Sato, N. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6385 · Cited by 106
Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
Asano, T., Watanabe, K., Kubota, N., Gunji, T., Omata, M., Kadowaki, T., & Ohnishi, S. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06039.x · Cited by 103
Curcumin Decreased Oxidative Stress, Inhibited NF‐ κ B Activation, and Improved Liver Pathology in Ethanol‐Induced Liver Injury in Rats
Samuhasaneeto, S., Thong‐Ngam, D., Kulaputana, O., Suyasunanont, D., & Klaikeaw, N. (2009) · BioMed Research International · doi:10.1155/2009/981963 · Cited by 125
Pregnane X Receptor Activators Inhibit Human Hepatic Stellate Cell Transdifferentiation In Vitro
Shepherd, E. L., Tucker, S. J., Marek, C. J., Durward, E., Leel, V., Bascal, Z. A., Monaghan, T. M., Koruth, M., Collie-Duguid, E. S. R., Mann, D. A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.012 · Cited by 101
Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
Speca, S., Rousseaux, C., Dubuquoy, C., Rieder, F., Vetuschi, A., Sferra, R., Giusti, I., Bertin, B., Dubuquoy, L., Gaudio, E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000618 · Cited by 98
Evaluation of PXL065–deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase II randomized placebo-controlled trial (DESTINY-1)
Harrison, S. A., Thang, C., Bolze, S., Dewitt, S., Hallakou-Bozec, S., Dubourg, J., Bedossa, P., Cusi, K., Ratziu, V., Grouin, J.-M., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.004 · Cited by 96
Curcumin improves sclerosing cholangitis in Mdr2 −/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation
Baghdasaryan, A., Claudel, T., Kosters, A., Gumhold, J., Silbert, D., Thüringer, A., Leski, K., Fickert, P., KARPEN, S., & Trauner, M. (2010) · Gut · doi:10.1136/gut.2009.186528 · Cited by 97
The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARγ in rat activated hepatic stellate cell in vitro
Zhou, Y., Zheng, S., Lin, J., Zhang, Q.-J., & Chen, A. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700532 · Cited by 93
In vitro reversion of activated primary human hepatic stellate cells
Taghdouini, A. E., Najimi, M., Sancho‐Bru, P., Sokal, E. M., & van Grunsven, L. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0031-z · Cited by 92
Leptin and liver fibrosis: A matter of fat
Marra, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.33369 · Cited by 92
Curcumin Eliminates Leptin’s Effects on Hepatic Stellate Cell Activation via Interrupting Leptin Signaling
Tang, Y., Zheng, S., & Chen, A. (2009) · Endocrinology · doi:10.1210/en.2008-1601 · Cited by 91
Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Zardi, E. M., Navarini, L., Sambataro, G., Piccinni, P., Sambataro, F., Spina, C., & Dobrina, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990136 · Cited by 92
Pregnenolone-16α-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms
MAREK, C. J., TUCKER, S. J., KONSTANTINOU, D. K., ELRICK, L. J., HAEFNER, D., SIGALAS, C., MURRAY, G. I., GOODWIN, B., & WRIGHT, M. C. (2005) · Biochemical Journal · doi:10.1042/bj20041598 · Cited by 89
Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma
Rumi, M. A. K., Sato, H., Ishihara, S., Kawashima, K., Hamamoto, S., Kazumori, H., Okuyama, T., Fukuda, R., Nagasue, N., & Kinoshita, Y. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1821 · Cited by 88
Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP 3 inflammasome pathway
Wu, X., Zhang, F., Xiong, X., Lu, C., Lian, N., Lu, Y., & Zheng, S. (2015) · IUBMB Life · doi:10.1002/iub.1348 · Cited by 88
Anti‐adipogenic regulation underlies hepatic stellate cell transdifferentiation
Tsukamoto, H., She, H., Hazra, S., Cheng, J. H., & Miyahara, T. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04573.x · Cited by 91
Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells
Lin, J., & Chen, A. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.20 · Cited by 86
Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor
Zheng, S., & Chen, A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2005 · Cited by 85
The antioxidant (−)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression
Chen, A., ZHANG, L., Xu, J., & Tang, J. M. (2002) · Biochemical Journal · doi:10.1042/bj20020894 · Cited by 84
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo
Rehan, V. K., Wang, Y., Patel, S. V., Santos, J., & Torday, J. S. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20407 · Cited by 82
Acetaldehyde stimulates the activation of latent transforming growth factor-β1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells
Chen, A. (2002) · Biochemical Journal · doi:10.1042/bj20020949 · Cited by 81
The Antioxidant (–)-Epigallocatechin-3-gallate Inhibits Rat Hepatic Stellate Cell Proliferation in Vitro by Blocking the Tyrosine Phosphorylation and Reducing the Gene Expression of Platelet-derived Growth Factor-β Receptor
Chen, A., & Zhang, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212042200 · Cited by 81
Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts
Li, L., Grenard, P., Nhieu, J. T. V., Julien, B., Mallat, A., Habib, A., & Lotersztajn, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00906-5 · Cited by 80
Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro
Yu, J. Q., Zhang, S., Chu, E. S., Go, M. Y. Y., Lau, R. H. Y., Zhao, J., Wu, C., Tong, L., Zhao, J., Poon, T. C. W., et al. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.006 · Cited by 81
Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells
Zheng, S., & Chen, A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00200.2006 · Cited by 77
Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice
Nan, Y., Fu, N., Wu, W., Liang, B.-L., Wang, R., Zhao, S., Zhao, J., & Yu, J. Q. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802530861 · Cited by 78
A critical review of endpoints for non-cirrhotic NASH therapeutic trials
Ratziu, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.001 · Cited by 74
Hyperoxia Augments Pulmonary Lipofibroblast-to-Myofibroblast Transdifferentiation
Rehan, V. K., & Torday, J. S. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:38:3:239 · Cited by 72
PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression1
Kai, S. U. N., Wang, Q., & Huang, X. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00299.x · Cited by 71
Novel Anti-fibrotic Therapies
McVicker, B. L., & Bennett, R. G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00318 · Cited by 74
Iron-induced oxidant stress in alcoholic liver fibrogenesis
Pietrangelo, A. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00126-5 · Cited by 68
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats
Leclercq, I. A. (2006) · Gut · doi:10.1136/gut.2005.079194 · Cited by 67
PPAR Gamma and Hepatic Stellate Cells
Hazra, S., Miyahara, T., Rippe, R. A., & Tsukamoto, H. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s7 · Cited by 66
Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand
Li, J., Kuruba, R., Wilson, A., Gao, X., Zhang, Y., & Li, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013955 · Cited by 66
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
Hellemans, K., Rombouts, K., Quartier, E., Dittié, A. S., Knorr, A., Michalik, L., Rogiers, V., Schuit, F., Wahli, W., & Geerts, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200376-jlr200 · Cited by 64
Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis
Zhang, F., Lu, Y., & Zheng, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.008 · Cited by 65
Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1
Kang, Q., & Chen, A. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.93 · Cited by 66
Molecular aspects of medicine: from experimental to clinical hepatology
Häussinger, D. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.001 · Cited by 62
Curcumin Inhibits srebp-2 Expression in Activated Hepatic Stellate Cells in Vitro by Reducing the Activity of Specificity Protein-1
Kang, Q., & Chen, A. (2009) · Endocrinology · doi:10.1210/en.2009-0517 · Cited by 60
Difficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitis
Leung, T.-K. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.4931 · Cited by 60
Peroxisome proliferator - activated receptor ? overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells
Jaster, R., Lichte, P., Fitzner, B., Brock, P., Glass, A. S., Karopka, T., Gierl, L., Koczan, D., Thiesen, H., Sparmann, G. H., et al. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00497.x · Cited by 60
Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines
Gong, L., Wei, F., Gonzalez, F. J., & Li, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000182 · Cited by 61
Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2
Lin, J., & Chen, A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.028 · Cited by 57
Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum
Chen, H., He, Y., Liu, W., & Zhang, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2905 · Cited by 56
The Necdin-Wnt Pathway Causes Epigenetic Peroxisome Proliferator-activated Receptor γ Repression in Hepatic Stellate Cells
Zhu, N., Wang, J., & Tsukamoto, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.156703 · Cited by 55
Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
Rombouts, K., & Marra, F. (2010) · Digestive Diseases · doi:10.1159/000282094 · Cited by 54
Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats
Wang, Z., Xu, J.-P., Zheng, Y.-C., Chen, W., Sun, Y.-W., Wu, Z.-Y., & Luo, M. (2011) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60009-x · Cited by 55
PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells
Zhou, Y., Jia, X., Wang, G., Wang, X., & Liu, J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0027-3 · Cited by 51
Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling
Sato-Matsubara, M., Matsubara, T., Daikoku, A., Okina, Y., Longato, L., Rombouts, K., Thủy, L. T. T., Adachi, J., Tomonaga, T., Ikeda, K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.793794 · Cited by 51
Modulatory effects of curcumin, silybin-phytosome and alpha-R-lipoic acid against thioacetamide-induced liver cirrhosis in rats
Ali, S. O., Darwish, H. A., & Ismail, N. A. E.-F. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.03.009 · Cited by 49

Authors: Galli, A., Crabb, D., Price, D., Ceni, E., Salzano, R., Surrenti, C., & Casini, A.
Affiliations: University of Florence (IT)
Indiana University Indianapolis (US)
Corresponding author: Casini, Alessandro
ORCID: Galli, Andrea
Crabb, David
Ceni, Elisabetta
Casini, Alessandro
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-01
Volume: 31
Issue: 1
Pages: 101-108
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.510310117
OpenAlex: W2118881723
Cited by: 197
References: 52
Citations by year: 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 7 · 2017: 9 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 9
FWCI: 4.57
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5722 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: PPARγ, hepatic stellate cells, platelet-derived growth factor, cell proliferation, alpha-smooth muscle actin, retinoic acid, MAPK signaling, liver fibrosis, transcriptional regulation
MeSH terms: Cell Differentiation, Cell Division, Cells, Cultured, Gene Expression Regulation, Humans, Liver, Platelet-Derived Growth Factor, RNA, Messenger, Thiazoles, Transcription Factors, Transcription, Genetic, Transfection, Prostaglandin D2, Gene Expression, Receptors, Cytoplasmic and Nuclear, Thiazolidinediones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks